Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Congressional DSHEA Amendment Potential Prompts NNFA Lobbying Activity

This article was originally published in The Tan Sheet

Executive Summary

NNFA is initiating a lobbying effort in response to concerns Congress might amend the Dietary Supplement Health & Education Act following the recent uproar over ephedra safety

You may also be interested in...

Ephedra Bill Likely To Be Subject Of Hearing Within The Next Month

A hearing on the "Ephedra Public Protection Act" (HR 1075), which would ban the sale of all ephedrine alkaloid-containing dietary supplements under certain conditions, is expected within the next month

Ephedra “Black Box” Warning Considered By FDA

FDA is suggesting that a "black box" warning appear on the principal display panel of all ephedrine alkaloid-containing dietary supplements, FDA Commissioner Mark McClellan, MD/PhD, said during a Feb. 28 briefing held in Washington, D.C

Supplement Trade Association Consolidation Urged By CRN’s Cordaro

The Council for Responsible Nutrition is looking to merge with other dietary supplement trade associations to build a more unified industry voice

Related Content


Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts